Description
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
| Cas No. | 639052-78-1 |
|---|---|
| Purity | ≥98% |
| Formula | C16H13ClN2OS |
| Formula Wt. | 316.80 |
| IUPAC Name | N-(5-Chloro-6-methyl-1,3-benzothiazol-2-yl)-2-phenylacetamide |
| Solubility | 100mM in DMSO |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Lee JW, Hirota T, Peters EC, et al. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angew Chem Int Ed Engl. 2011 Nov 4;50(45):10608-11. PMID: 21954091.
Cdc42 GTPase inhibitor.
Camptothecin derivative; topoisomerase I inhibi...
Impurity of diclofenac
Walrycin response regulator inhibitor.
Kavalactone originally found in Piper methystic...
PKA inhibitor.
Protease inhibitor.
Prevents MHC II antigen presentation.
Naphthodianthrone found in Hypericum; dopamine ...
Endogenous neuropeptide, also known as substanc...
Laminin-derived nonapeptide.
Endogenous glycosaminoglycan that is produced b...
PDK1 and Akt inhibitor.
Recombinant HCV antigen fragment.
Polypeptide; peptidoglycan inhibitor.
HDAC inhibitor. May reduce blood pressure in hy...
AT1 inhibitor.
1-Naphthalenacetic acid derivative, NSAID; COX-...
EGFR inhibitor.
Synthetic peptide, vasopressin analog; AVPR1 ag...